O	0	3	Ten
O	3	4	-
O	4	8	year
O	9	15	follow
O	15	16	-
O	16	18	up
O	19	26	results
O	27	29	of
O	30	31	a
O	32	42	randomised
O	43	53	controlled
O	54	59	study
O	60	69	comparing
B-control	70	75	level
I-control	75	76	-
I-control	76	77	I
O	78	80	vs
B-intervention	81	86	level
I-intervention	86	87	-
I-intervention	87	90	III
I-intervention	91	99	axillary
I-intervention	100	105	lymph
I-intervention	106	110	node
I-intervention	111	121	dissection
O	122	125	for
O	126	133	primary
O	134	140	breast
O	141	147	cancer
O	147	148	.

O	149	152	The
O	153	157	most
O	158	169	appropriate
O	170	175	level
O	176	178	of
O	179	187	axillary
O	188	198	dissection
O	199	202	for
O	203	209	breast
O	210	216	cancer
O	217	224	remains
O	225	232	unclear
O	232	233	.

O	234	237	The
O	238	245	present
O	246	256	randomised
O	257	262	study
O	263	271	compared
O	272	275	the
O	276	285	treatment
O	286	293	results
O	294	296	of
O	297	302	level
O	302	303	-
O	303	304	I
O	305	307	vs
O	308	313	level
O	313	314	-
O	314	317	III
O	318	328	dissection
O	329	331	in
O	332	334	T1
O	334	335	/
O	335	336	2
O	336	337	/
O	337	338	3
O	339	342	and
O	343	345	N0
O	345	346	/
O	346	348	1a
O	348	349	/
O	349	351	1b
O	352	353	(
O	353	357	1987
O	358	362	UICC
O	363	377	classification
O	377	378	)
B-eligibility	379	385	breast
I-eligibility	386	392	cancer
I-eligibility	393	400	without
I-eligibility	401	408	distant
I-eligibility	409	419	metastasis
O	419	420	.

O	421	428	Between
O	429	433	1995
O	434	437	and
O	438	442	1997
O	442	443	,
B-total-participants	444	447	522
O	448	456	patients
O	457	461	were
O	462	470	enrolled
O	470	471	,
O	472	475	and
B-total-participants	476	479	514
O	480	484	were
O	485	493	eligible
O	493	494	.

O	495	499	They
O	500	504	were
O	505	515	stratified
O	516	520	into
O	521	527	breast
O	527	528	-
O	528	538	conserving
O	539	546	surgery
O	547	549	or
O	550	560	mastectomy
O	560	561	,
O	562	565	and
O	566	570	then
O	571	578	further
O	579	589	stratified
O	590	594	into
O	595	600	level
O	600	601	-
O	601	604	III
O	605	615	dissection
O	616	617	(
O	617	622	group
O	622	623	-
O	623	624	A
O	624	625	,
O	626	627	n
O	627	628	=
B-intervention-participants	628	631	258
O	631	632	)
O	633	635	or
O	636	641	level
O	641	642	-
O	642	643	I
O	644	654	dissection
O	655	656	(
O	656	661	group
O	661	662	-
O	662	663	B
O	663	664	,
O	665	666	n
O	666	667	=
B-control-participants	667	670	256
O	670	671	)
O	671	672	.

O	673	676	All
O	677	685	patients
O	686	690	were
O	691	696	given
O	697	701	oral
O	702	703	5
O	703	704	-
O	704	716	fluorouracil
O	717	719	at
O	720	723	200
O	724	726	mg
O	727	730	day
O	730	731	-
O	731	732	1
O	733	736	and
O	737	746	tamoxifen
O	747	749	at
O	750	752	20
O	753	755	mg
O	756	759	day
O	759	760	-
O	760	761	1
O	761	762	,
O	763	768	daily
O	769	772	for
O	773	774	2
O	775	780	years
O	780	781	.

O	782	787	Group
O	787	788	-
O	788	789	A
O	790	798	resulted
O	799	801	in
O	802	803	a
O	804	817	significantly
O	818	824	longer
B-outcome	825	834	operation
I-outcome	835	839	time
O	840	841	(
B-iv-cont-mean	841	843	77
I-iv-cont-mean	843	844	.
I-iv-cont-mean	844	845	0
O	846	848	vs
B-cv-cont-mean	849	851	60
I-cv-cont-mean	851	852	.
I-cv-cont-mean	852	853	5
I-cv-cont-mean	854	857	min
O	857	858	,
O	859	860	P
O	860	861	<
O	861	862	0
O	862	863	.
O	863	867	0001
O	867	868	)
O	869	872	and
O	873	886	significantly
O	887	893	larger
B-outcome	894	899	blood
I-outcome	900	904	loss
O	905	906	(
B-iv-cont-mean	906	908	62
I-iv-cont-mean	908	909	.
I-iv-cont-mean	909	910	1
O	911	913	vs
B-cv-cont-mean	914	916	48
I-cv-cont-mean	916	917	.
I-cv-cont-mean	917	918	1
I-cv-cont-mean	919	921	ml
O	921	922	,
O	923	924	P
O	924	925	<
O	925	926	0
O	926	927	.
O	927	931	0001
O	931	932	)
O	933	937	than
O	938	943	group
O	943	944	-
O	944	945	B
O	945	946	,
O	947	950	but
O	951	953	in
O	954	956	no
O	957	968	significant
O	969	980	differences
O	981	983	in
O	984	987	the
O	988	999	frequencies
O	1000	1002	of
B-outcome	1003	1006	arm
I-outcome	1007	1013	oedema
I-outcome	1014	1017	and
I-outcome	1018	1026	shoulder
I-outcome	1027	1038	disturbance
O	1038	1039	.

O	1040	1045	Group
O	1045	1046	-
O	1046	1047	A
O	1048	1056	resulted
O	1057	1059	in
O	1060	1061	a
O	1062	1075	significantly
O	1076	1082	larger
B-outcome	1083	1089	number
I-outcome	1090	1092	of
I-outcome	1093	1102	dissected
I-outcome	1103	1108	nodes
O	1109	1113	than
O	1114	1119	group
O	1119	1120	-
O	1120	1121	B
O	1122	1123	(
B-iv-cont-mean	1123	1125	18
I-iv-cont-mean	1125	1126	.
I-iv-cont-mean	1126	1127	7
O	1128	1130	vs
B-cv-cont-mean	1131	1133	14
I-cv-cont-mean	1133	1134	.
I-cv-cont-mean	1134	1135	8
O	1135	1136	,
O	1137	1138	P
O	1138	1139	<
O	1139	1140	0
O	1140	1141	.
O	1141	1145	0001
O	1145	1146	)
O	1146	1147	,
O	1148	1151	but
O	1152	1154	in
O	1155	1157	no
O	1158	1169	differences
O	1170	1172	in
O	1173	1176	the
B-outcome	1177	1183	number
I-outcome	1184	1186	of
I-outcome	1187	1195	involved
I-outcome	1196	1201	nodes
O	1202	1203	(
B-iv-cont-mean	1203	1204	1
I-iv-cont-mean	1204	1205	.
I-iv-cont-mean	1205	1207	54
O	1208	1210	vs
B-cv-cont-mean	1211	1212	1
I-cv-cont-mean	1212	1213	.
I-cv-cont-mean	1213	1215	44
O	1215	1216	)
O	1216	1217	.

O	1218	1223	There
O	1224	1228	were
O	1229	1231	no
O	1232	1243	significant
O	1244	1255	differences
O	1256	1258	in
O	1259	1262	the
B-outcome	1263	1265	10
I-outcome	1265	1266	-
I-outcome	1266	1270	year
I-outcome	1271	1278	overall
O	1279	1282	and
B-outcome	1283	1290	disease
I-outcome	1290	1291	-
I-outcome	1291	1295	free
I-outcome	1296	1304	survival
I-outcome	1305	1310	rates
O	1310	1311	:
B-iv-bin-percent	1312	1314	89
I-iv-bin-percent	1314	1315	.
I-iv-bin-percent	1315	1316	6
O	1317	1320	and
B-iv-bin-percent	1321	1323	76
I-iv-bin-percent	1323	1324	.
I-iv-bin-percent	1324	1325	6
I-iv-bin-percent	1325	1326	%
O	1327	1330	for
O	1331	1336	group
O	1336	1337	-
O	1337	1338	A
O	1339	1341	vs
B-cv-bin-percent	1342	1344	87
I-cv-bin-percent	1344	1345	.
I-cv-bin-percent	1345	1346	8
O	1347	1350	and
B-cv-bin-percent	1351	1353	74
I-cv-bin-percent	1353	1354	.
I-cv-bin-percent	1354	1355	1
I-cv-bin-percent	1355	1356	%
O	1357	1360	for
O	1361	1366	group
O	1366	1367	-
O	1367	1368	B
O	1368	1369	,
O	1370	1382	respectively
O	1382	1383	.

O	1384	1386	In
O	1387	1397	conclusion
O	1397	1398	,
O	1399	1404	level
O	1404	1405	-
O	1405	1408	III
O	1409	1419	dissection
O	1420	1428	resulted
O	1429	1431	in
O	1432	1433	a
O	1434	1440	longer
B-outcome	1441	1450	operation
I-outcome	1451	1455	time
O	1456	1459	and
O	1460	1467	greater
B-outcome	1468	1473	blood
I-outcome	1474	1478	loss
O	1479	1483	than
O	1484	1489	level
O	1489	1490	-
O	1490	1491	I
O	1491	1492	,
O	1493	1496	but
O	1497	1500	did
O	1501	1504	not
O	1505	1512	improve
O	1513	1516	the
B-outcome	1517	1525	survival
I-outcome	1526	1530	rate
O	1530	1531	.

O	1532	1537	Level
O	1537	1538	-
O	1538	1541	III
O	1542	1552	dissection
O	1553	1555	is
O	1556	1559	not
O	1560	1561	a
O	1562	1573	recommended
O	1574	1581	surgery
O	1582	1585	for
O	1586	1588	T1
O	1588	1589	-
O	1589	1590	3
O	1590	1591	/
O	1591	1593	N0
O	1593	1594	-
O	1594	1596	1b
O	1597	1603	breast
O	1604	1610	cancer
O	1610	1611	.
